-The Business Standard Politics means sugarcane gets Maharashtra's scarce water The drought in a large part of Maharashtra, said to be the worst since 1972, may have been triggered by poor rainfall in the last monsoon season - but it has been compounded by mismanagement of the available water. Nearly one-third of the state's population living in the 15 drought-hit districts in and around the Marathwada region is facing a severe scarcity...

-PTI The government today approved road projects worth Rs 4,620 crore in Assam and Madhya Pradesh for the widening of National Highways. All the four projects, including three in Assam for widening of stretches of National Highways 37 under Special Accelerated Road Development Programme in North Eastern Region (SARDP-NE) at a cost of Rs 1,933 crore, were approved by the Cabinet Committee on Economic Affairs (CCEA). "The CCEA has given its approval for...

-The Indian Express A day after the deadline for implementation of the Right To Education (RTE) Act expired, representatives of the Delhi State Public Schools Association (DSPSA) met Chief Minister Sheila Dikshit and Education Minister Kiran Walia, seeking a reprieve. Speaking to Newsline, Walia said, "We have already brought down the minimum area requirement to 200 square meters. Beyond this, there are concerns of fire safety and other issues." She said the delegation...

-The Hindu   The government does it purely on the strength of a certificate issued by the district administration Even as the recent affidavit submitted by the Union Ministry of Environment and Forests (MoEF) before the Supreme Court in the Vedanta case has caused dismay among tribal communities and activists for the dilution of its stand on diverting forest lands of tribal communities, the Ministry has gone a step further and allowed diversion...

-The Business Standard Court denies Swiss drug firm patent protection for its anti-cancer drug Glivec; domestic industry hails verdict The Supreme Court on Monday dismissed Novartis AG's appeal for patent protection of its anti-cancer drug, Glivec, putting an end to a seven-year battle between the Swiss drug maker, several domestic generic manufacturers, as well as patient groups fighting for affordable medicines. A Bench of judges Aftab Alam and Ranjana Desai said in a...